Login / Signup

Use of ivermectin and factors associated with the prevention and/or treatment of COVID-19: a cross-sectional online survey in the province of Chincha, Peru.

José Fernando Salvador-CarrilloLuz Campos-LozaDavid Guillen-CarbajalJorge OsadaAlejandra ZevallosJunior Smith Torres-Roman
Published in: F1000Research (2024)
Most people in Chincha used ivermectin during the second wave of the COVID-19 pandemic. The main factors associated with the use of ivermectin for the prevention/treatment of COVID-19 were age ≥50 years, having a technical education level, having had symptoms with negative/no diagnosis or positive diagnosis, and contact with people infected with SARS-CoV-2.
Keyphrases
  • sars cov
  • coronavirus disease
  • respiratory syndrome coronavirus
  • healthcare
  • south africa
  • drug administration
  • quality improvement
  • combination therapy